Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1762435

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1762435

Fabry Disease Treatment Market Size, Share, & Industry Analysis Report By Route of Administration (Intravenous Route and Oral Route), By Therapy, By Distribution Channel, By Region - Market Forecast, 2025-2034

PUBLISHED:
PAGES: 129 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

The fabry's disease treatment market size is expected to reach USD 5,321.12 million by 2034, according to a new study by Polaris Market Research. The report "Fabry's Disease Treatment Market Size, Share, & Industry Analysis Report By Route of Administration (Intravenous Route and Oral Route), By Therapy, By Distribution Channel, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Fabry's disease treatment market focuses on the development and commercialization of therapies designed to manage the clinical manifestations of Fabry disease, a rare X-linked lysosomal storage disorder caused by a deficiency of the a-galactosidase A enzyme. This enzymatic deficit leads to the systemic accumulation of globotriaosylceramide (Gb3), resulting in progressive damage to vital organs such as the kidneys, heart, and nervous system. The market is being propelled by advances in targeted enzyme replacement therapy (ERT) and the growing availability of oral chaperone therapies that aim to stabilize the misfolded enzymes. Rising awareness among healthcare providers and improved diagnostic capabilities are contributing to earlier detection, expanding the eligible treatment population. Strategic investments in rare disease research, including orphan drug development and precision medicine platforms, are fostering innovation and accelerating regulatory approvals. Market participants are increasingly focusing on gene therapy pipelines that offer the potential for durable or curative outcomes, reflecting a key trend toward next-generation modalities.

Improved reimbursement frameworks and collaborative research initiatives between biopharmaceutical companies and academic institutions are creating new opportunities for the development of differentiated treatment solutions. There is also a rising emphasis on developing treatments tailored to late-onset and atypical phenotypes, addressing unmet needs in diverse patient subgroups. Increasing efforts to monitor long-term efficacy and safety through post-marketing surveillance and real-world evidence generation are reinforcing confidence in therapeutic choices. Overall, the market reflects a dynamic landscape marked by high unmet need, significant clinical complexity, and a robust drive toward innovation in both biologic and small-molecule therapies.

Fabry's Disease Treatment Market Report Highlights

By route of administration, in 2024, the intravenous route segment accounted for the largest share. Intravenous (IV) administration is the primary method for delivering enzyme replacement therapy (ERT) in Fabry disease treatment.

Based on therapy, in 2024, the enzyme replacement therapy (ERT) segment accounted for approximately 60% of the share. ERT involves intravenous infusions of synthetic enzymes such as agalsidase alfa or beta, which help break down Gb3, slowing disease progression and alleviating symptoms such as neuropathic pain, gastrointestinal issues, and organ dysfunction.

In 2024, the Asia Pacific Fabry's disease treatment market accounted for the largest share due to increasing awareness of rare genetic disorders and the expansion of diagnostic infrastructure in the region.

The Latin America Fabry's disease treatment market is projected to grow significantly from 2025 to 2034. Healthcare providers, governments, and advocacy groups in LATAM are prioritizing early diagnosis and access to therapies, fueling the regional market expansion.

A few global key players include Amicus Therapeutics, Inc.; CANbridge Life Sciences Ltd.; Chiesi Farmaceutici S.p.A.; Idorsia Pharmaceuticals Ltd.; ISU ABXIS Co., Ltd.; JCR Pharmaceuticals Co., Ltd.; Protalix Biotherapeutics Inc.; Sangamo Therapeutics, Inc.; Sanofi; and Takeda Pharmaceutical.

Polaris Market Research has segmented the Fabry's disease treatment market report on the basis of route of administration, therapy, distribution channel, and region:

By Route of Administration Outlook (Revenue, USD Million, 2020-2034)

Intravenous Route

Oral Route

By Therapy Outlook (Revenue, USD Million, 2020-2034)

Enzyme Replacement Therapy (ERT)

Substrate Reduction Therapy (SRT)

Others

By Distribution Channel Outlook (Revenue, USD Million, 2020-2034)

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of the Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM5760

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Fabry's Disease Treatment Market Insights

  • 4.1. Fabry's Disease Treatment Market - Market Snapshot
  • 4.2. Fabry's Disease Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Personalized Medicine Adoption in Fabry Disease Care
      • 4.2.1.2. Expansion of Reimbursement Policies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Shortage of Skilled Personal
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Fabry's Disease Treatment Market Trends
  • 4.6. Value Chain Analysis

5. Global Fabry's Disease Treatment Market, by Route of Administration

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • 5.3. Intravenous Route
    • 5.3.1. Global Fabry's Disease Treatment Market, by Intravenous Route, by Region, 2020-2034 (USD Million)
  • 5.4. Oral Route
    • 5.4.1. Global Fabry's Disease Treatment Market, by Oral Route, by Region, 2020-2034 (USD Million)

6. Global Fabry's Disease Treatment Market, by Therapy

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • 6.3. Enzyme Replacement Therapy (ERT)
    • 6.3.1. Global Fabry's Disease Treatment Market, by Enzyme Replacement Therapy (ERT), by Region, 2020-2034 (USD Million)
  • 6.4. Substrate Reduction Therapy (SRT)
    • 6.4.1. Global Fabry's Disease Treatment Market, by Substrate Reduction Therapy (SRT), by Region, 2020-2034 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Fabry's Disease Treatment Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Fabry's Disease Treatment Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • 7.3. Hospital Pharmacies
    • 7.3.1. Global Fabry's Disease Treatment Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Million)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Fabry's Disease Treatment Market, by Retail Pharmacies, by Region, 2020-2034 (USD Million)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Fabry's Disease Treatment Market, by Online Pharmacies, by Region, 2020-2034 (USD Million)

8. Global Fabry's Disease Treatment Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Fabry's Disease Treatment Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Fabry's Disease Treatment Market - North America
    • 8.3.1. North America: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.3.2. North America: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
    • 8.3.3. North America: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.3.4. Fabry's Disease Treatment Market - U.S.
      • 8.3.4.1. U.S.: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.3.4.2. U.S.: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.3.4.3. U.S.: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.3.5. Fabry's Disease Treatment Market - Canada
      • 8.3.5.1. Canada: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.4. Fabry's Disease Treatment Market - Europe
    • 8.4.1. Europe: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.4.2. Europe: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
    • 8.4.3. Europe: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.4. Fabry's Disease Treatment Market - UK
      • 8.4.4.1. UK: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.5. Fabry's Disease Treatment Market - France
      • 8.4.5.1. France: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.4.5.2. France: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.4.5.3. France: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.6. Fabry's Disease Treatment Market - Germany
      • 8.4.6.1. Germany: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.7. Fabry's Disease Treatment Market - Italy
      • 8.4.7.1. Italy: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.8. Fabry's Disease Treatment Market - Spain
      • 8.4.8.1. Spain: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.9. Fabry's Disease Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.10. Fabry's Disease Treatment Market - Russia
      • 8.4.10.1. Russia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.11. Fabry's Disease Treatment Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.5. Fabry's Disease Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.4. Fabry's Disease Treatment Market - China
      • 8.5.4.1. China: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.5.4.2. China: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.5.4.3. China: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.5. Fabry's Disease Treatment Market - India
      • 8.5.5.1. India: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.5.5.2. India: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.5.5.3. India: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.6. Fabry's Disease Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.7. Fabry's Disease Treatment Market - Japan
      • 8.5.7.1. Japan: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.8. Fabry's Disease Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.9. Fabry's Disease Treatment Market - South Korea
      • 8.5.9.1. South Korea: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.10. Fabry's Disease Treatment Market - Australia
      • 8.5.10.1. Australia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.11. Fabry's Disease Treatment Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.6. Fabry's Disease Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.4. Fabry's Disease Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.5. Fabry's Disease Treatment Market - UAE
      • 8.6.5.1. UAE: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.6. Fabry's Disease Treatment Market - Israel
      • 8.6.6.1. Israel: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.7. Fabry's Disease Treatment Market - South Africa
      • 8.6.7.1. South Africa: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.8. Fabry's Disease Treatment Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.7. Fabry's Disease Treatment Market - Latin America
    • 8.7.1. Latin America: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.4. Fabry's Disease Treatment Market - Mexico
      • 8.7.4.1. Mexico: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.5. Fabry's Disease Treatment Market - Brazil
      • 8.7.5.1. Brazil: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.6. Fabry's Disease Treatment Market - Argentina
      • 8.7.6.1. Argentina: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.7. Fabry's Disease Treatment Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Amicus Therapeutics, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. CANbridge Life Sciences Ltd.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Chiesi Farmaceutici S.p.A.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Idorsia Pharmaceuticals Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. ISU ABXIS Co., Ltd.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. JCR Pharmaceuticals Co., Ltd.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Protalix Biotherapeutics Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Sangamo Therapeutics, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sanofi
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Takeda Pharmaceutical
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
Product Code: PM5760

List of Tables:

  • Table 1 Global Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 2 Global Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 3 Global Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 4 North America: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 5 North America: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 6 North America: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 7 U.S.: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 8 U.S.: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 9 U.S.: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 10 Canada: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 11 Canada: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 12 Canada: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 13 Europe: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 14 Europe: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 15 Europe: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 16 UK: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 17 UK: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 18 UK: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 19 France: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 20 France: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 21 France: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 22 Germany: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 23 Germany: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 24 Germany: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 25 Italy: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 26 Italy: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 27 Italy: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 28 Spain: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 29 Spain: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 30 Spain: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 31 Netherlands: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 32 Netherlands: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 33 Netherlands: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 34 Russia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 35 Russia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 36 Russia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 37 Rest of Europe: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 38 Rest of Europe: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 39 Rest of Europe: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 40 Asia Pacific: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 41 Asia Pacific: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 42 Asia Pacific: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 43 China: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 44 China: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 45 China: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 46 India: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 47 India: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 48 India: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 49 Malaysia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 50 Malaysia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 51 Malaysia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 52 Japan: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 53 Japan: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 54 Japan: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 55 Indonesia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 56 Indonesia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 57 Indonesia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 58 South Korea: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 59 South Korea: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 60 South Korea: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 61 Australia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 62 Australia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 63 Australia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 64 Rest of Asia Pacific: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 65 Rest of Asia Pacific: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 66 Rest of Asia Pacific: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 67 Middle East & Africa: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 68 Middle East & Africa: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 69 Middle East & Africa: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 70 Saudi Arabia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 71 Saudi Arabia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 72 Saudi Arabia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 73 UAE: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 74 UAE: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 75 UAE: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 76 Israel: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 77 Israel: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 78 Israel: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 79 South Africa: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 80 South Africa: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 81 South Africa: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 82 Rest of Middle East & Africa: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 83 Rest of Middle East & Africa: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 84 Rest of Middle East & Africa: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 85 Latin America: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 86 Latin America: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 87 Latin America: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 88 Mexico: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 89 Mexico: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 90 Mexico: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 91 Brazil: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 92 Brazil: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 93 Brazil: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 94 Argentina: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 95 Argentina: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 96 Argentina: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 97 Rest of Latin America: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 98 Rest of Latin America: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 99 Rest of Latin America: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Fabry's Disease Treatment Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Route of Administration
  • Figure 7. Global Fabry's Disease Treatment Market, by Route of Administration, 2024 & 2034 (USD Million)
  • Figure 8. Market by Therapy
  • Figure 9. Global Fabry's Disease Treatment Market, by Therapy, 2024 & 2034 (USD Million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Fabry's Disease Treatment Market, by Distribution Channel, 2024 & 2034 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!